Skip to main content
. 2006 Mar;27(3):589–592.

Clinical, cognitive, and mean diffusivity measures for the HIV patients

Patient No. Clival Calvarial MSK CD4 Viral Load (log10) Therapy
1 0.000691 0.000854 2 174 3.914 3-TC, Kaletra,* Ziagen
2 0.001017 0.000784 1 220 1.903 3-TC, Indinavir,* Nevirapine
3 0.000907 0.000866 1 108 2.623 ddl, Efavirenz, DMP266, Viread
4 0.000771 0.001021 1 397 1.903 Efavirenz, DMP266, Viread, Ziagen, Kaletra*
5 0.000873 0.000851 .5 81 3.204 Kaletra,* Combivir
6 0.000757 0.000770 .5 373 1.903 3-TC, d4T, Viracept*
7 0.000427 0.000729 .5 427 1.903 Ziagen, Kaletra*
8 0.000822 0.000890 .5 310 1.903 Norvir,* Saquinavir,* Ziagen
9 0.000941 0.000740 .5 24 5.49 None (drug holiday)
10 0.000612 0.000844 1 122 4.699 3-TC, Norvir,* Amprenavir, Ziagen, Kaletra,* Tenofovir
11 0.000632 0.001137 0.5 240 3.322 3-TC, AZT, ddl, Ziagen, Kaletra,* T20, Tenofovir

Note:—MSK indicates Memorial Sloan Kettering rating scale.

*

Protease inhibitor.